ScholarIQanswers from OpenAlex

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

PaperCitations, authors & open-access status

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update have?

ScholarIQcitation count

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update has 1,541 citations in the OpenAlex counts ScholarIQ stores.

When was Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update published?

ScholarIQyear

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update has 2020 year in the ScholarIQ index.

What is the open-access status of Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update?

ScholarIQoa status

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update has bronze oa status in the ScholarIQ index.

What is the DOI of Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update?

ScholarIQdoi

The DOI for Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update is on the source record.

What is the PMID of Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update?

ScholarIQpmid

The PMID for Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update is on the source record.

What is the OpenAlex record for Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update?

ScholarIQopenalex

The OpenAlex for Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial